SHANGHAI, Feb. 4, 2020 /PRNewswire/ -- In response to
the evolving global epidemic created by the outbreak of 2019-nCOV
coronavirus, 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a
leading integrated online and offline healthcare platform, is
providing a series of services and charity donations to help those
affected.
111's Internet hospital is offering free online medical
consultation in Hubei Province,
the epicenter, in an effort to alleviate pressure on overburdened
hospitals and to curtail the coronavirus' further spread. Since its
launch on January 24, 2020, the
service has provided approximately 3,000 daily online consultations
per day.
Critical to the public at large keeping outdoor activities to a
minimum, the Company is also providing free online drug refill
services to patients with chronic diseases across the country. The
online refill and home delivery service is part of 111's integrated
online and offline platform service, consisting of an Internet
hospital, online pharmacy, and offline network of 210,000
pharmacies. Patients with prescriptions can receive medications at
home by submitting their prescription and placing their orders
online (to be reviewed by 111's online medical professionals).
Patients without prescriptions may obtain free e-prescriptions
subject to consultation with 111's online medical
professionals.
As part of its initiative, 111 has also donated 100,000
protective masks to front-line medical professionals, public
security personnel, and traffic police officers in Wuhan, Hubei
Province, and donated 100,000 units of
Radix Isatidis Granule (traditional Chinese medicine) to the public
across the country for flu prevention. 111 continued to provide
services during the Spring Festival holiday. In order to maintain
adequate supply and meet the demand for protective medical
equipment, 111 has, since January 24,
2020, coordinated closely with its strategic pharmaceutical
company partners—including CR Jiangzhong, Yiling Pharmaceutical,
HEC Group, Jiangsu Wuzhong and Bayer—purchasing RMB 30 million (USD 4.2
million) of urgently needed drugs and medical supplies on
the market for sale to meet the extraordinary demand.
Dr. Gang Yu, Co-Founder and Executive Chairman of 111, said: "As
a public company with a strong commitment to social responsibility,
111 will continue to provide urgently needed resources to medical
professionals and patients as quickly as possible. We are offering
our full support to win the battle against the coronavirus, guided
by the appropriate government departments."
In addition, 111 has rolled out a real-time epidemic monitoring
system on its official website to provide information about the
coronavirus outbreak to the public.
111's real-time epidemic monitoring system link:
https://m.111.com.cn/yyw/activities/broadcast/?from=singlemessage#/home
Safe Harbor Statement
This press release contains forward-looking statements. These
statements constitute "forward-looking" statements within the
meaning of Section 21E of the Securities Exchange Act of 1934, as
amended, and as defined in the U.S. Private Securities Litigation
Reform Act of 1995. These forward-looking statements can be
identified by terminology such as "will," "expects," "anticipates,"
"future," "intends," "plans," "believes," "estimates," "target,"
"confident" and similar statements. Among other things, the
Business Outlook and quotations from management in this
announcement, as well as 111's strategic and operational plans,
contain forward-looking statements. 111 may also make written or
oral forward-looking statements in its periodic reports to the U.S.
Securities and Exchange Commission, in its annual report to
shareholders, in press releases and other written materials and in
oral statements made by its officers, directors or employees to
third parties. Such statements are based upon management's current
expectations and current market and operating conditions and relate
to events that involve known or unknown risks, uncertainties and
other factors, all of which are difficult to predict and many of
which are beyond the Company's control. Forward-looking statements
involve inherent risks, uncertainties and other factors that could
cause actual results to differ materially from those contained in
any such statements. Potential risks and uncertainties include, but
are not limited to, uncertainties as to the Company's ability
comply with extensive and evolving regulatory requirements, its
ability to compete effectively in the evolving PRC general health
and wellness market, its ability to manage the growth of its
business and expansion plans, its ability to achieve or maintain
profitability in the future, its ability to control the risks
associated with its pharmaceutical retail and wholesale businesses,
and the Company's ability to meet the standards necessary to
maintain listing of its ADSs on the Nasdaq Global Market, including
its ability to cure any non-compliance with Nasdaq's continued
listing criteria. Further information regarding these and other
risks, uncertainties or factors is included in the Company's
filings with the U.S. Securities and Exchange Commission. All
information provided in this press release is as of the date of
this press release, and 111 does not undertake any obligation to
update any forward-looking statement as a result of new
information, future events or otherwise, except as required under
applicable law.
About 111, Inc.
111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading
integrated online and offline healthcare platform in China. The Company provides hundreds of
millions of consumers with better access to pharmaceutical products
and healthcare services directly through its online retail pharmacy
and indirectly through its offline pharmacy network. 111 also
offers online healthcare services through its internet hospital, 1
Clinic, which provides consumers with cost-effective and convenient
online consultation and electronic prescription services. In
addition to providing direct services to consumers through its
online retail pharmacy, 111 also enables offline pharmacies to
better serve their customers. The Company's online wholesale
pharmacy, 1 Drug Mall, serves as a one-stop shop for pharmacies to
source a vast selection of pharmaceutical products. The Company's
new retail platform, by integrating the front and back ends of the
pharmaceutical supply chain, has formed a smart supply chain, which
transforms the flow of pharmaceutical products to pharmacies and
modernizes how they serve their customers.
For more information on 111, please visit http://ir.111.cn.
For more information, please contact:
111, Inc.
IR Director
Ms. Monica Mu
E-mail: ir@111.cn
Christensen
In China
Mr. Christian Arnell
Phone: +86-10-5900-1548
E-mail: carnell@christensenir.com
In US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email: lbergkamp@christensenir.com
View original
content:http://www.prnewswire.com/news-releases/111-inc-offers-free-online-consultation-and-prescription-refill-services-300998470.html
SOURCE 111, Inc.